Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Giovanni Targher

Showing results (61-70 of 638) with videos related to

Pageof 64
Sort By:
Endocrine|March 6, 2014
Lower 25-hydroxyvitamin D3 levels and increased risk of liver diseases: is there a causal link?Giovanni Targher, Christopher D Byrne
Metabolic Syndrome and Related Disorders|February 26, 2015
A Perspective on Metabolic Syndrome and Nonalcoholic Fatty Liver DiseaseGiovanni Targher, Christopher D Byrne
Hepatology (Baltimore, Md.)|August 3, 2018
Ad Libitum Mediterranean or Low-Fat Diets as Treatments for Nonalcoholic Fatty Liver Disease?Giovanni Targher, Christopher D Byrne
Diabetes, Obesity & Metabolism|December 10, 2024
Hepatic thyroid hormone receptor-β signalling: Mechanisms and recent advancements in the treatment of metabolic dysfunction-associated steatohepatitisStergios A Polyzos, Giovanni Targher
Seminars in Thrombosis and Hemostasis|February 12, 2013
Diagnosis and management of nonalcoholic fatty liver disease and its hemostatic/thrombotic and vascular complicationsGiovanni Targher, Christopher D Byrne
Nature Reviews. Gastroenterology & Hepatology|November 20, 2019
What's new in NAFLD pathogenesis, biomarkers and treatment?Christopher D Byrne, Giovanni Targher
Arteriosclerosis, Thrombosis, and Vascular Biology|May 16, 2015
Circulating Markers of Liver Function and Cardiovascular Disease RiskGiovanni Targher, Christopher D Byrne
European Heart Journal|May 5, 2018
Liver fat content, non-alcoholic fatty liver disease, and risk of ischaemic heart diseaseChristopher D Byrne, Giovanni Targher
Arteriosclerosis, Thrombosis, and Vascular Biology|April 19, 2014
Ectopic fat, insulin resistance, and nonalcoholic fatty liver disease: implications for cardiovascular diseaseChristopher D Byrne, Giovanni Targher
Diabetologia|April 8, 2016
EASL-EASD-EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease: is universal screening appropriate?Christopher D Byrne, Giovanni Targher
Pageof 64

Showing results (61-70 of 638) with videos related to

Sort By:
Pageof 64
Endocrine|March 6, 2014
Lower 25-hydroxyvitamin D3 levels and increased risk of liver diseases: is there a causal link?Giovanni Targher, Christopher D Byrne
Metabolic Syndrome and Related Disorders|February 26, 2015
A Perspective on Metabolic Syndrome and Nonalcoholic Fatty Liver DiseaseGiovanni Targher, Christopher D Byrne
Hepatology (Baltimore, Md.)|August 3, 2018
Ad Libitum Mediterranean or Low-Fat Diets as Treatments for Nonalcoholic Fatty Liver Disease?Giovanni Targher, Christopher D Byrne
Diabetes, Obesity & Metabolism|December 10, 2024
Hepatic thyroid hormone receptor-β signalling: Mechanisms and recent advancements in the treatment of metabolic dysfunction-associated steatohepatitisStergios A Polyzos, Giovanni Targher
Seminars in Thrombosis and Hemostasis|February 12, 2013
Diagnosis and management of nonalcoholic fatty liver disease and its hemostatic/thrombotic and vascular complicationsGiovanni Targher, Christopher D Byrne
Nature Reviews. Gastroenterology & Hepatology|November 20, 2019
What's new in NAFLD pathogenesis, biomarkers and treatment?Christopher D Byrne, Giovanni Targher
Arteriosclerosis, Thrombosis, and Vascular Biology|May 16, 2015
Circulating Markers of Liver Function and Cardiovascular Disease RiskGiovanni Targher, Christopher D Byrne
European Heart Journal|May 5, 2018
Liver fat content, non-alcoholic fatty liver disease, and risk of ischaemic heart diseaseChristopher D Byrne, Giovanni Targher
Arteriosclerosis, Thrombosis, and Vascular Biology|April 19, 2014
Ectopic fat, insulin resistance, and nonalcoholic fatty liver disease: implications for cardiovascular diseaseChristopher D Byrne, Giovanni Targher
Diabetologia|April 8, 2016
EASL-EASD-EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease: is universal screening appropriate?Christopher D Byrne, Giovanni Targher
Pageof 64